Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Phase Logo
Phase Growth Score
52
CB Rank
108588
Heat Score
69
Phase provides 3D-printing medical devices for microfluidics.
Founded
obfuscation
PrivateGrant Cornelius, North Carolina, United States11-50 phase.am/
3D Printing
3D Technology
Biotechnology
Medical Device
Overview

Phase
Total Funding
obfuscation
Growth Score
52
Heat Score
69

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score52
-2 pts
in past quarter
Heat Score 69
-1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Phase

CB Rank
108588
Phase provides 3D-printing medical devices for microfluidics.
Founded
obfuscation
PrivateGrant Cornelius, North Carolina, United States11-50 phase.am/
3D Printing
3D Technology
Biotechnology
Medical Device

Funding Rounds

Grant
OBF
in
obfuscation
Debt Financing
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Details

Legal Name Phase Inc.,
Also Known As Phase AM
Operating Status Active
Company Type For Profit
About the Company
Phase provides 3D-printing medical devices for microfluidics. Phase’s proprietary platform enables PDMS (Sylgard 184) to be 3D printed at a scale and resolution that was previously unattainable.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

3DPDMS 3D-Printed Microfluidics
A platform for 3D printing microfluidic devices using PDMS and other biocompatible materials at commercial scale and high resolution.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Phase Logo
Grant - Phase
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - Phase Logo
Grant - Phase
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - Phase Logo
Grant - Phase
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - Phase Logo
Grant - Phase
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - Phase Logo
Grant - Phase
1
obfuscation
National Institutes of HealthGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Phase Logo
Grant - Phase
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - Phase Logo
Grant - Phase
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - Phase Logo
Grant - Phase
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - Phase Logo
Grant - Phase
1
obfuscation
National Institutes of HealthGrant
obfuscation
Grant - Phase Logo
Grant - Phase
1
obfuscation
National Institutes of HealthGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
National Institutes of Health Logo
National Institutes of Health
Yes
Grant - Phase Logo
Grant - Phase
—
National Institutes of Health Logo
National Institutes of Health
Yes
Grant - Phase Logo
Grant - Phase
—
National Institutes of Health Logo
National Institutes of Health
Yes
Grant - Phase Logo
Grant - Phase
—
National Institutes of Health Logo
National Institutes of Health
Yes
Grant - Phase Logo
Grant - Phase
—
National Institutes of Health Logo
National Institutes of Health
Yes
Grant - Phase Logo
Grant - Phase
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News

News and Press

News•Mar 24, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$53.5KThis year, Phase is projected to spend $53.5K on IT, according to Aberdeen.

Active Website Tech Count

2Phase is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Phase's headquarters? Phase is located in Cornelius, North Carolina, United States.Who invested in Phase? Phase has 4 investors including National Institutes of Health and  North Carolina Biotechnology Center.When was the last funding round for Phase? Phase closed its last funding round on
obfuscation
from a Grant round.Who are Phase's competitors? Alternatives and possible competitors to Phase may include Nano Dimension, Readily3D, and  Cellink.How much funding has Phase raised to date? Phase has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|